N M Kaplan

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi Primary aldosteronism: evidence against a second epidemic
    Norman M Kaplan
    University of Texas Southwestern Medical School, Dallas, TX, USA
    J Hypertens 30:1899-902. 2012
  2. ncbi Clinical trials for hypertension: expectations fulfilled and unfulfilled
    Norman M Kaplan
    Hypertension Division, Department of Internal Medicine, University of Texas, Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Hypertension 49:257-9. 2007
  3. ncbi What can we expect from new guidelines?
    Norman M Kaplan
    Department of Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390 8899, USA
    Med Clin North Am 88:141-8, ix. 2004
  4. ncbi The current epidemic of primary aldosteronism: causes and consequences
    Norman M Kaplan
    University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Room CS8 102, Dallas, TX 75390 8899, USA
    J Hypertens 22:863-9. 2004
  5. ncbi Déjà vu for primary aldosteronism
    Norman M Kaplan
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Lancet 371:1890-1. 2008
  6. ncbi The two-edged sword: controlling hypertension without destroying the patient
    Norman M Kaplan
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8899, USA
    Blood Press 13:212-3. 2004
  7. ncbi Systemic hypertension: an overview of the problem
    Norman M Kaplan
    Department of Internal Medicine, Division of Hypertension, The University of Texas Southwestern Medical Center, Dallas, TX 75390 8899, USA
    Semin Nephrol 25:191-3. 2005
  8. ncbi The place of diuretics in preventing cardiovascular events
    N M Kaplan
    The University of Texas Southwestern Medical Center, Dallas, TX 75235 8899, USA
    J Hum Hypertens 18:S29-32. 2004
  9. ncbi Hypertension curriculum review: lifestyle modifications for prevention and treatment of hypertension
    Norman M Kaplan
    University of Texas, Southwestern Medical Center, Department of Medicine, 5323 Harry Hines Boulevard, Dallas, TX 75235-8899, USA
    J Clin Hypertens (Greenwich) 6:716-9. 2004
  10. ncbi Are more tests needed?
    Norman M Kaplan
    Department of Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Clin Hypertens (Greenwich) 10:232-3. 2008

Detail Information

Publications53

  1. ncbi Primary aldosteronism: evidence against a second epidemic
    Norman M Kaplan
    University of Texas Southwestern Medical School, Dallas, TX, USA
    J Hypertens 30:1899-902. 2012
    ....
  2. ncbi Clinical trials for hypertension: expectations fulfilled and unfulfilled
    Norman M Kaplan
    Hypertension Division, Department of Internal Medicine, University of Texas, Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Hypertension 49:257-9. 2007
  3. ncbi What can we expect from new guidelines?
    Norman M Kaplan
    Department of Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390 8899, USA
    Med Clin North Am 88:141-8, ix. 2004
    ....
  4. ncbi The current epidemic of primary aldosteronism: causes and consequences
    Norman M Kaplan
    University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Room CS8 102, Dallas, TX 75390 8899, USA
    J Hypertens 22:863-9. 2004
    ....
  5. ncbi Déjà vu for primary aldosteronism
    Norman M Kaplan
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
    Lancet 371:1890-1. 2008
  6. ncbi The two-edged sword: controlling hypertension without destroying the patient
    Norman M Kaplan
    University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8899, USA
    Blood Press 13:212-3. 2004
  7. ncbi Systemic hypertension: an overview of the problem
    Norman M Kaplan
    Department of Internal Medicine, Division of Hypertension, The University of Texas Southwestern Medical Center, Dallas, TX 75390 8899, USA
    Semin Nephrol 25:191-3. 2005
    ..Attempts at prevention are critical but likely are ineffectual. Therefore, the delivery and acceptance of current medical regimens must be improved...
  8. ncbi The place of diuretics in preventing cardiovascular events
    N M Kaplan
    The University of Texas Southwestern Medical Center, Dallas, TX 75235 8899, USA
    J Hum Hypertens 18:S29-32. 2004
    ..As lower blood pressure goals of therapy have been found to be needed, diuretic enhancement of other agents' efficacy has become even more essential. With such low doses, side effects are minimal in degree and infrequent in appearance...
  9. ncbi Hypertension curriculum review: lifestyle modifications for prevention and treatment of hypertension
    Norman M Kaplan
    University of Texas, Southwestern Medical Center, Department of Medicine, 5323 Harry Hines Boulevard, Dallas, TX 75235-8899, USA
    J Clin Hypertens (Greenwich) 6:716-9. 2004
  10. ncbi Are more tests needed?
    Norman M Kaplan
    Department of Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Clin Hypertens (Greenwich) 10:232-3. 2008
  11. ncbi Resistant hypertension
    Norman M Kaplan
    Department of Internal Medicine, Division of Hypertension, The University of Texas, Southwestern Medical Center, Dallas, Texas 75390, USA
    J Hypertens 23:1441-4. 2005
    ..This paper reviews the major causes of resistant hypertension and provides specific recommendations for the evaluation and management of patients with this threatening condition...
  12. ncbi Vascular outcome in type 2 diabetes: an ADVANCE?
    Norman M Kaplan
    Department of Internal Medicine, Hypertension Division, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Lancet 370:804-5. 2007
  13. ncbi Is there an unrecognized epidemic of primary aldosteronism? Con
    Norman M Kaplan
    University of Texas Southwestern Medical Center, Department of Internal Medicine, Hypertension Division, Dallas, TX 75390, USA
    Hypertension 50:454-8; discussion 454-8. 2007
  14. ncbi Controversies in hypertension
    Norman M Kaplan
    University of Texas Southwestern Medical Center, Dallas, TX, USA
    Lancet 367:168-76. 2006
    ..We provide the background for these controversies, followed by some opinions on how to guide practitioners to offer more effective management of hypertension...
  15. ncbi A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly
    Norman M Kaplan
    Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235, USA
    Curr Hypertens Rep 5:362-3. 2003
  16. ncbi Nonpharmacologic treatment of hypertension in primary health care
    Norman M Kaplan
    Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235, USA
    Curr Hypertens Rep 5:361-2. 2003
  17. ncbi Combination therapy for hypertension
    Norman M Kaplan
    University of Texas Southwestern Medical School, Dallas, TX 75390, USA
    Nat Rev Cardiol 6:270-1. 2009
    ....
  18. ncbi Can treating the diastolic blood pressure below a certain value increase cardiovascular risk?
    Norman M Kaplan
    University of Texas Southwestern Medical School, Dallas, TX 75390 8586, USA
    Curr Cardiol Rep 13:517-9. 2011
    ..Caution is needed in the more intensive and widespread treatment of hypertensive patients to avoid a J-curve...
  19. ncbi Current diagnosis and treatment of primary aldosteronism
    Norman M Kaplan
    University of Texas Southwestern Medical Center at Dallas, TX 75390 8586, USA
    Expert Rev Cardiovasc Ther 8:1527-30. 2010
    ..Many of these patients are not hypokalemic and can safely be treated without the need for a costly and usually negative work-up...
  20. ncbi The diastolic j curve: alive and threatening
    Norman M Kaplan
    Department of Medicine, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX 75390 8586
    Hypertension 58:751-3. 2011
    ....
  21. ncbi Suggestions for improving the effectiveness of oral presentations
    Norman M Kaplan
    Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 75390-8899, USA
    J Investig Med 50:419-20. 2002
  22. ncbi Prehypertension: is it relevant for nephrologists?
    Norman M Kaplan
    Department of Internal Medicine, Division of Hypertension, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75390 8586, USA
    Clin J Am Soc Nephrol 4:1381-3. 2009
    ..It covers more than 60 million people in the United States and nephrologists will increasingly be involved with them. This review describes its relevance to nephrologists...
  23. ncbi Treating prehypertension: a review of the evidence
    Norman M Kaplan
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 25390, USA
    Curr Hypertens Rep 10:326-9. 2008
    ..Two trials have attempted to document the value of short-term drug therapy to prevent the progression of BP to overt hypertension, but no outcome studies are currently available...
  24. ncbi Primary aldosteronism: A contrarian view
    Norman M Kaplan
    University of Texas Southwestern Medical School, Dallas, TX 75390, USA
    Rev Endocr Metab Disord 12:49-52. 2011
    ..Moreover, even if these uncertainties are overcome, the eventual treatment of most who have PA can be provided without the need for extensive testing and expensive treatment...
  25. ncbi [The challenge to treat hypertensive patients with type 2 diabetes]
    N M Kaplan
    , , Dallas, USA
    Presse Med 31:S25-6. 2002
    ..THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice...
  26. ncbi Hypertension trials: 1990 to 2000
    N M Kaplan
    Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, 75390-8899, USA
    Curr Opin Nephrol Hypertens 10:501-5. 2001
    ..There are no concerns about the use of calcium antagonists in diabetic patients...
  27. ncbi Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence
    N M Kaplan
    University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Ann Intern Med 135:1079-83. 2001
    ..Attention should also be directed toward nonpharmacologic and pharmacologic control of hyperglycemia and dyslipidemia...
  28. ncbi Hypertension and diabetes
    N M Kaplan
    University of Texas Southwestern Medical School, Dallas, TX 75390-8899, USA
    J Hum Hypertens 16:S56-60. 2002
    ..Fortunately, the appropriate use of lifestyle changes and multiple drugs will always slow and often stop the progression of this damage...
  29. ncbi Low-dose combination therapy: the rationalization for an ACE inhibitor and a calcium channel blocker in higher risk patients
    N M Kaplan
    Department of Medicine, The University of Texas Southwestern Medical Center, Dallas 75390-8899, USA
    Am J Hypertens 14:8S-11S. 2001
    ..Also, combining agents from different classes results in complementary mechanisms of action that provide other cardiovascular protective benefits...
  30. ncbi Treatment of coexisting diabetes and hypertension
    N M Kaplan
    University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8899, USA
    Curr Cardiol Rep 3:498-503. 2001
    ..Despite the costs and difficulties of achieving adequate control of these diseases, such patients can be protected from the debilities of diabetes and hypertension...
  31. ncbi The early morning rise in blood pressure is related mainly to ambulation
    A F Khoury
    University of Texas Southwestern Medical Center, Department of Internal Medicine, Dallas 75235-8899
    Am J Hypertens 5:339-44. 1992
    ..The early morning rise in blood pressure and pulse is mainly related to arising from bed. Possible ways to reduce the abrupt rise in blood pressure and the increase in cardiovascular events that occur after arising are suggested...
  32. ncbi The challenge of managing multiple cardiovascular risk factors
    N M Kaplan
    University of Texas Southwestern Medical Center, Dallas 75235-8899, USA
    Am J Hypertens 10:167S-169S. 1997
    ..As has been noted in the other papers in this supplement, the combination of an ACE inhibitor and a calcium antagonist is particularly attractive, not only to treat hypertension, but also to ameliorate other cardiovascular risk factors...
  33. ncbi Management of hypertensive patients with multiple cardiovascular risk factors
    N M Kaplan
    University of Texas Southwestern Medical Center, Dallas 75390-8899, USA
    Am J Hypertens 14:221S-224S. 2001
    ..If active therapy is needed for established hypertension, all modifiable unhealthy lifestyles should be addressed along with appropriate drug therapy...
  34. ncbi The 6th joint national committee report (JNC-6): new guidelines for hypertension therapy from the USA
    N M Kaplan
    Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas 75235 8899, USA
    Keio J Med 47:99-105. 1998
    ..Recommendations are made for improved adherence to therapy, therapy of resistant hypertension and hypertensive crises...
  35. ncbi The editor's roundtable: concurrent hypertension and dyslipidemia
    Vincent E Friedewald
    University of Texas Health Sciences Center at Houston, Houston, TX, USA
    Am J Cardiol 99:134-44. 2007
  36. ncbi Recent clinical trials: the good, the bad, and the misleading
    Norman M Kaplan
    Hypertension 52:608-9. 2008
  37. ncbi The meaning of ALLHAT
    Norman M Kaplan
    J Hypertens 21:233-4. 2003
  38. ncbi Primary aldosteronism: an update on screening, diagnosis and treatment
    Norman M Kaplan
    J Hypertens 26:1708-9; author reply 1709-11. 2008
  39. ncbi Treatment of hypertension: remaining issues after the Anglo-Scandinavian Cardiac Outcomes Trial
    Norman M Kaplan
    Hypertension 47:10-3. 2006
  40. ncbi The ASCOT trial: a closer look
    Norman M Kaplan
    J Hypertens 24:211-4. 2006
  41. ncbi TROPHY: a trial that may change clinical practice
    Norman M Kaplan
    Curr Hypertens Rep 8:359-60. 2006
  42. ncbi Hypochondriasis
    Norman M Kaplan
    N Engl J Med 346:783-4. 2002
  43. ncbi Exercise and atherosclerosis
    Norman M Kaplan
    Ann Intern Med 141:890; discussion 890. 2004
  44. ncbi Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism
    Norman M Kaplan
    J Hypertens 24:1899; author reply 1899-900. 2006
  45. ncbi Morning surge in blood pressure
    Norman M Kaplan
    Circulation 107:1347. 2003
  46. ncbi Trial of Preventing Hypertension (TROPHY): design and 2-year progress report
    Norman M Kaplan
    Hypertension 44:125-6. 2004
  47. ncbi Task Force 5: systemic hypertension
    Norman M Kaplan
    J Am Coll Cardiol 45:1346-8. 2005
  48. ncbi An updated meta-analysis with a few surprises
    Norman M Kaplan
    Hypertension 46:257-8. 2005
  49. ncbi Control of blood pressure: does it matter which agent you use?
    Marvin Moser
    J Clin Hypertens (Greenwich) 9:964-73. 2007
    ..The authors maintained full control of the discussion and the resulting content of this article...
  50. ncbi [New European guidelines for the management of arterial hypertension: an American perspective]
    Norman M Kaplan
    Pol Arch Med Wewn 117:281-2. 2007
  51. ncbi Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Preventi
    Clive Rosendorff
    Veterans Health Administration, USA
    Circulation 115:2761-88. 2007
  52. ncbi Acupuncture for hypertension: can 2500 years come to an end?
    Norman M Kaplan
    Hypertension 48:815. 2006
  53. ncbi Renin-angiotensin system blockade: therapeutic implications beyond blood pressure control
    Norman M Kaplan
    J Clin Hypertens (Greenwich) 9:2-3. 2007